A randomized dental study found numerical advantages for ketamine–midazolam combinations, but did not establish superiority on its predefined behavioral success comparison.
A specific success rule
Eighty-four children were assigned to intranasal ketamine–midazolam, oral ketamine–midazolam, or oral midazolam. Videotaped behavior was rated using a structured scale. Success required quiet behavior for at least sixty percent of the session.
Success occurred in 50.0%, 46.4%, and 32.1%, respectively. The overall comparison had p=0.360, and the reported odds-ratio intervals for the combinations were wide and crossed one.
Why a larger count is not definitive
The estimates are compatible with benefit but also with substantial uncertainty. Minor adverse events occurred in forty-four percent overall and did not significantly differ by group. Small samples cannot establish equivalent safety.
The investigators modified parts of the planned statistical approach because a meaningful multivariable model was not supported. Onset and recovery differences were not evaluated fully because administration timing was standardized for blinding.
Forensic application
State the exact behavior threshold and distinguish it from completing treatment, analgesia, or lack of recall. The study does not prove a combination works better for every child or support replacing its nonsignificant comparison with a favorable-looking percentage alone.
Source paper
Original analysis of the supplied journal article, identified as PMC6411109.
Leave a Reply